Mohapatra Satyakam, Nayak Mihir Ranjan, Dash Manaswini
Department of Psychiatry, SCB Medical College, Mental Health Institute, Cuttack, Odisha, India.
Department of Psychology, Clinical Psychologist Cum Lecturer in Psychology, GM University, Sambalpur, Odisha, India.
Indian J Psychol Med. 2017 Nov-Dec;39(6):756-759. doi: 10.4103/IJPSYM.IJPSYM_61_17.
Opioid substitution therapy (OST) is an evidence-based intervention for opiate-dependent persons that replaces illicit drug use with medically prescribed, orally administered opiates such as buprenorphine and methadone. OST reduces HIV risk behaviors and harms associated with injecting opioid. Most of the evidence for OST effectiveness has been generated in middle- and high-income countries where programs are mostly located in dedicated health-care settings; evidence regarding the outcomes of OST programs in low-income countries where OST is often provided in grassroots settings such as drop-in centers is limited.
To study the sociodemographic variables, HIV ELISA status, HIV risk behavior, comorbid substance use pattern, and required dose of buprenorphine used for treatment of injection drug users (IDUs) attending oral substitution therapy (OST) center at a tertiary health care center.
A total of IDUs aged 18-60 years who attended the OST center during 1-year period at a government medical college are included in the study.
Majority of the IDUs are male with mean age of 32.8 years. The mean dose of buprenorphine used for the substitution was 4.6 mg/day at the start of therapy. Most of the IDUs are of lower educational status and educated up to primary or middle school. 32.50% of the participants who are unemployed are totally dependent on the family. Most common substance abuse among IDU users were tobacco (74.17%), followed by heroine (57.5%). High-risk behavior found among OST clients was unprotected sexual intercourse (19.17%), sharing needle (11.67%), and sexual intercourse with multiple partners (6.67%). HIV ELISA testing showed positive among 2 (1.67%).
These findings have relevance to other parts of India and Asia, where injecting drug use is common and is a first step toward filling the gap in knowledge regarding the effectiveness of community-based OST programs delivered in resource-constrained settings.
阿片类药物替代疗法(OST)是一种针对阿片类药物依赖者的循证干预措施,用医学处方的口服阿片类药物(如丁丙诺啡和美沙酮)替代非法药物使用。OST可降低艾滋病毒风险行为以及与注射阿片类药物相关的危害。OST有效性的大部分证据来自中高收入国家,这些国家的项目大多位于专门的医疗保健机构;而关于在低收入国家基层场所(如救助中心)提供OST项目结果的证据有限。
研究在一家三级医疗保健中心接受口服替代疗法(OST)的注射吸毒者(IDU)的社会人口统计学变量、艾滋病毒酶联免疫吸附测定(ELISA)状态、艾滋病毒风险行为、合并物质使用模式以及治疗所需的丁丙诺啡剂量。
本研究纳入了在一所政府医学院的OST中心接受为期1年治疗的18至60岁的IDU。
大多数IDU为男性,平均年龄32.8岁。治疗开始时用于替代的丁丙诺啡平均剂量为4.6毫克/天。大多数IDU教育程度较低,最高为小学或初中。32.50%的失业参与者完全依赖家庭。IDU使用者中最常见的物质滥用是烟草(74.17%),其次是海洛因(57.5%)。在OST服务对象中发现的高风险行为有不安全性行为(19.17%)、共用针头(11.67%)以及与多个性伴侣发生性行为(6.67%)。艾滋病毒ELISA检测显示2人(1.67%)呈阳性。
这些发现与印度和亚洲的其他地区相关,在这些地区注射吸毒很常见,这是填补资源受限环境下基于社区的OST项目有效性知识空白的第一步。